What's new in the medical management of pediatric epilepsy?

Research output: Contribution to journalArticle


Epilepsy affects approximately 45 per 100,000 children per year. While many cases respond favorably to antiepileptic therapy, approximately 20% will prove to be medically intractable. This paper reviews some of the recently identified important metabolic and autoimmune etiologies for which there are specific therapies. Additionally, newer antiepileptic medications, including rufinamide, lacosamide, retigabine, eslicarbazepine and brivaracetam and newer dietary options, including the modified Atkins diet and low-glycemic index diet are discussed.

Original languageEnglish (US)
Pages (from-to)S30-S34
JournalCanadian Journal of Neurological Sciences
Issue number6 SUPPL.6
StatePublished - Nov 1 2012


ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this